- Global Advancement of Nuclear Medicine: KSNM 60 Years of Achievements
-
Scott A
- KMID: 2519267
- Nucl Med Mol Imaging.
- 2021 Aug;55(4):149-150.
- doi: 10.1007/s13139-021-00700-y
-
- CITED
-
- Close
- SHARE
-
- Close
- KSNM60 in Cardiology: Regrowth After a Long Pause
-
Cho SG, Kong E, Kang W, Paeng J, Henry Bom HS, Cho I
- KMID: 2519268
- Nucl Med Mol Imaging.
- 2021 Aug;55(4):151-161.
- doi: 10.1007/s13139-021-00702-w
The Korean Society of Nuclear Medicine (KSNM) is celebrating its 60th anniversary in honor of the nuclear medicine professionals who have dedicated their efforts towards research, academics, and the more... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidental Detection of Ischemic Myocardium on 68 Ga-FAPI PET/CT
-
Chandra P, Nath S, Krishnamoorthy J, Sogunuru G
- KMID: 2519273
- Nucl Med Mol Imaging.
- 2021 Aug;55(4):194-198.
- doi: 10.1007/s13139-021-00704-8
Recent studies using Ga-68-labeled fibroblast activation protein inhibitors (FAPI) PET have shown strong association between focal uptake of FAPI in myocardium and presence of coronary artery disease. We present an... -
- CITED
-
- Close
- SHARE
-
- Close
- Mismatched Imaging Findings of Prostate Cancer Diagnosis: 68 Ga-PSMA PET/CT vs mpMRI
-
Lopci E, Colombo P, Lazzeri M
- KMID: 2519274
- Nucl Med Mol Imaging.
- 2021 Aug;55(4):199-202.
- doi: 10.1007/s13139-021-00701-x
Multiparametric magnetic resonance imaging (mpMRI) is the modality of choice for initial diagnosis of prostate cancer (PCa), including biopsy-naïve patients. Nevertheless, clinicians must be aware of the possibility that up... -
- CITED
-
- Close
- SHARE
-
- Close
- 18F-FDG PET/CT Evaluation of Thymomas: a Pictorial Review
-
Murad V, Kim E
- KMID: 2519272
- Nucl Med Mol Imaging.
- 2021 Aug;55(4):186-193.
- doi: 10.1007/s13139-021-00705-7
The World Health Organization classification divides thymomas according to morphology, epithelial component, and cell atypia. They are grouped into 3 large subgroups: low-risk thymomas (types A, AB, and B1), high-risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Does the Incremental Value of 123 I-Metaiodobenzylguanidine SPECT/ CT over Planar Imaging Justify the Increase in Radiation Exposure?
-
Ben-Sellem D, Ben-Rejeb N
- KMID: 2519270
- Nucl Med Mol Imaging.
- 2021 Aug;55(4):173-180.
- doi: 10.1007/s13139-021-00707-5
Purpose Planar scintigraphy with 123 I-radiolabeled metaiodobenzylguanidine (123 I-mIBG) is an important imaging modality to evaluate neuroblastoma. In recent years, Single Photon Emission Computed Tomography combined with Computed Tomography (SPECT/CT)... -
- CITED
-
- Close
- SHARE
-
- Close
- Transarterial Radioembolization Agents: a Review of the Radionuclide Agents and the Carriers
-
Alrfooh A, Patel A, Laroia S
- KMID: 2519269
- Nucl Med Mol Imaging.
- 2021 Aug;55(4):162-172.
- doi: 10.1007/s13139-021-00709-3
Liver tumors, both primary and secondary to metastatic disease, remain a major challenge, with an increasing incidence. In this context, taking advantage of the dual blood supply of the liver,... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Tc-99 m-MIBI Scan in the Assessment of the Cystic Thyroid Nodule
-
Hurtado-López LM, Martínez-Duncker C
- KMID: 2519271
- Nucl Med Mol Imaging.
- 2021 Aug;55(4):181-185.
- doi: 10.1007/s13139-021-00708-4
Purpose A non-surgical therapeutic option requires assurance that a cystic thyroid nodule with non-diagnostic cytology is benign. This work was undertaken to determine whether Tc-99 m-MIBI scan (MIBI) findings can guide... -
- CITED
-
- Close
- SHARE
-
- Close
